Skip to content
Resources > Reports

Navigating Biopharma Policy: 2025 Changes and a Look Ahead

By Sara Mallatt, Director of Healthcare Research and Sean Carmichael
IndustryLife Sciences & Healthcare

Biopharma firms are grappling with a turbulent and complex policy landscape. The threat of 100% tariffs on imported branded drugs have fundamentally altered business strategy for firms, spurring dealmaking with the federal government in exchange for tariff relief. Heightened policy uncertainty is forcing manufacturers to reevaluate pricing and go-to-market strategies, with a severe expected revenue impact.

AlphaSense recently hosted a webinar with Dr. Robert Popovian, Chief Science Policy Officer at the Global Health Living Foundation to discuss these issues and more. This report leverages key insights from Dr. Popovian and those available in AlphaSense to explore the key policy shifts shaping the biopharma ecosystem.

About the Authors

  • Sara Mallatt, Director of Healthcare Research

    Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.

  • Sean Carmichael

    Sean is a Business & Finance Editor at AlphaSense, specializing in sector-specific content production. Previously, he spent nearly a decade in various roles across financial services, where he was responsible for equity research and content generation geared toward institutional investors.

Explore more

All articles

Mid-Year AI Checkpoint: The Shift from Wow to Work

The first half of 2026 marked a turning point for AI. The focus shifted away from breakthrough demos to the harder questions of deployment, integration, and real-world impact. As AI became more deeply embedded in products, workflows, and business operations, organizations faced new questions around measurement, governance, workforce impact, trust, and control.
Report
Mid-Year AI Checkpoint: The Shift from Wow to Work, by Sarah Hoffman. A graphic with a timeline, a sparkling marker, and an AIAIAI logo.

A Tale of Two Economies: Divergences Shaping Financial Services in H2 2026

In this report, we explore key expert and analyst perspectives on the relevant themes shaping the financial services landscape for H2, including scaled AI infrastructure, diversification and asset re-positioning, a deepening K-shaped economy bearing resemblance to the ’70s, and a wave of IPO and deal activity prevailing despite macroeconomic headwinds.
Report
Title slide for "A Tale of Two Economies: Divergences Shaping Financial Services in H2 2026" by Barb Tague, featuring an illustration of a signpost and a bar chart.

Global Oil and Gas Market: Iran War Fallout and Future Outlook

Drawing on broker research, industry tracking data, and expert analysis available in the AlphaSense platform, this report covers how governments, corporations, and investors are adapting amid uncertainty.
ReportEnergy
Title slide for "Global Oil and Gas Market: Iran War Fallout and Future Outlook," featuring an isometric illustration of an oil tanker and barrels.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.